Breast Cancers: Clinical Trials

1 trial for Breast Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Breast Cancers: new trials by email Literature Review of Breast Cancers trials Research Report on Breast Cancers

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer
Pembrolizumab, Deescalation - Breast Cancers, Triple Negative Breast Cancer (TNBC)
Phase 3RecruitingUNICANCER24542025-07-232026-07-23

Narrower conditions

Breast Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

pembrolizumab (1)

Sponsors

UNICANCER (1)

Countries

Belgium (1)  ·  France (1)

Top investigators

Joana Mourato Ribiero (1)